Newsroom

Meet us at bio:cap – Europe’s Life Science & AI Investival that
connects breakthrough science to the funding that turns ideas into impact.

Let us spotlight how YUMAB’s innovative antibody drug discovery platform transforms cutting-edge science into fast-track drug development as investable venture.

We look forward to meeting you in Berlin!